mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
0.0088 |
0.8 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
-0.0094 |
0.8 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.8 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |